Gene · 6752
Papers3,968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,968
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Expression of Somatostatin Receptors in the Small Intestine during Postnatal Ontogenesis. | Bull Exp Biol Med | 2024 | 39762694 | PubTator, text mining | PubMed |
| Characterization of Epithelial-Mesenchymal and Neuroendocrine Differentiation States in Pancreatic and Small Cell Ovarian Tumor Cells and Their Modulation by TGF-β1 and BMP-7. | Cells | 2024 | 39682758 | PubTator, text mining | PubMed |
| Characterization of Somatostatin Receptor 2 Gene Expression and Immune Landscape in Sinonasal Malignancies. | Cancers (Basel) | 2024 | 39682120 | PubTator, text mining | PubMed |
Metachronous Second Primary in the Form of Nasopharyngeal Carcinoma Following Treatment of Small Cell Neuroendocrine Carcinoma of the Head and Neck: Dual Tracer PET/CT Findings Highlighting SSTR2 Expression and Its Theranostic Implications. | World J Nucl Med | 2024 | 39677340 | PubTator, text mining | PubMed |
| Metastasis of WHO Grade II Meningioma With Subsequent Pathological T12 Fracture: A Case Report. | JBJS Case Connect | 2024 | 39666836 | PubTator, text mining | PubMed |
| Exploring key features of selectivity in somatostatin receptors through molecular dynamics simulations. | Comput Struct Biotechnol J | 2024 | 39660216 | PubTator, text mining | PubMed |
| Histopathological Evaluation of Somatostatin Receptor 2 Expression in Myocarditis-Rationale for the Diagnostic Use of Somatostatin Receptor Imaging. | Diagnostics (Basel) | 2024 | 39518342 | PubTator, text mining | PubMed |
| Insulinoma with suspected mutant somatostatin receptor expression according to histological examination. | Clin Case Rep | 2024 | 39507000 | PubTator, text mining | PubMed |
| Clinicopathological correlations in 38 cases of gastroenteropancreatic high-grade neuroendocrine neoplasms. | Front Oncol | 2024 | 39484039 | PubTator, text mining | PubMed |
| Somatostatin Receptor Type 2 as a Potential Marker of Local Myocardial Inflammation in Myocardial Infarction: Morphologic Data on Distribution in Infarcted and Normal Human Myocardium. | Biomedicines | 2024 | 39457491 | PubTator, text mining | PubMed |
| eSOMA-DM1, a Maytansinoid-Based Theranostic Small-Molecule Drug Conjugate for Neuroendocrine Tumors. | Bioconjug Chem | 2024 | 39395152 | PubTator, text mining | PubMed |
| Pituitary gigantism due to a novel AIP germline splice-site variant. | Endocr Oncol | 2024 | 39391823 | PubTator, text mining | PubMed |
| Peptide-guided adaptor-CAR T-Cell therapy for the treatment of SSTR2-expressing neuroendocrine tumors. | Oncoimmunology | 2024 | 39376579 | PubTator, text mining | PubMed |
| Clinicopathological and molecular genetic insights into EBV-positive inflammatory follicular dendritic cell sarcoma. | Hum Pathol | 2024 | 39370049 | PubTator, text mining | PubMed |
| Theranostic strategies in sarcoma: preliminary clinical evidence. | Expert Opin Investig Drugs | 2024 | 39367699 | PubTator, text mining | PubMed |
| Targeted radionuclide therapy for patients with central nervous system metastasis: Overlooked potential? | Neuro Oncol | 2024 | 39351771 | PubTator, text mining | PubMed |
| Heterogeneous SSTR2 target expression and a novel KIAA1549::BRAF fusion clone in a progressive metastatic lesion following 177Lutetium-DOTATATE molecular radiotherapy in neuroblastoma: a case report. | Front Oncol | 2024 | 39324010 | PubTator, text mining | PubMed |
| Theranostics with somatostatin receptor antagonists in SCLC: Correlation of 68Ga-SSO120 PET with immunohistochemistry and survival. | Theranostics | 2024 | 39310095 | PubTator, text mining | PubMed |
| FTO-mediated DSP m6A demethylation promotes an aggressive subtype of growth hormone-secreting pituitary neuroendocrine tumors. | Mol Cancer | 2024 | 39304899 | PubTator, text mining | PubMed |
| Resolution of Breast Cancer in a Patient With Thyroid Stimulating Hormone-Secreting Pituitary Neuroendocrine Tumor With the Combination of Chemotherapy and Lanreotide. | Cureus | 2024 | 39238765 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6752/papers?page=13